Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV, page-158

Can't believe the pessimism here. It just goes to show the high level investor fatigue in BIT.

The news today is excellent. It is the brief forerunner of further analysis that will take BIT further. The detailed analysis is what other parties will be examining. There is no reason to expect that the final analysis won't deliver. Today's prelim strongly suggests so.

But of course, the market is made from trader sentiment, and judging from many of the comments above, the sentiment is tired.

This will change soon enough. But who cares if the tired don't last the distance. The price can fall and it is only the paper value for holders that decreases. Some will even increrase their holding. I purchased more options today.

Talk about a case of not seeing the forrest for the trees.